Inhibitors of human immunodeficiency virus replication

US10954252B1 · kind B1 · utility

Assignee

• ViiV Healthcare UK (No.5) Limited · GB

Inventors

• Suresh D. Babu · Pennington, US
• Makonen Belema · North Haven, US
• John A. Bender · Middletown, US
• Christiana I. Iwuagwu · Wallingford, US
• John F. Kadow · Wallingford, US
• Selvakumar Kumaravel · Bengaluru, IN
• Pulicharla Nagalakshmi · Bengaluru, IN
• B. Narasimhulu Naidu · Durham, US
• Manoj Patel · Berlin, US
• Kevin Peese · Haddam, US
• Ramkumar Rajamani · Wallingford, US
• Mark G. Saulnier · Haddam, US
• Alan Xiangdong Wang · Guilford, US

Key dates

• Filing date: May 1, 2018
• Grant date: Mar 23, 2021
• Expiry date: May 1, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K45/06
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.